Beximco Pharmaceuticals Limited Sponsored GDR RegS Statistics
Beximco Pharmaceuticals Limited Sponsored GDR RegS (BXP) Stock Statistics & Valuation Metrics
Total Valuation
Beximco Pharmaceuticals Limited Sponsored GDR RegS has a market cap or net worth of GBX 66.74B. The enterprise value is GBX 229.05M.
- Market Cap
- GBX 66.74B
- Enterprise Value
- GBX 229.05M
Share Statistics
Beximco Pharmaceuticals Limited Sponsored GDR RegS has 446,112,100 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 446,112,100
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Beximco Pharmaceuticals Limited Sponsored GDR RegS’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
- Return on Equity (ROE)
- ―
- Return on Assets (ROA)
- ―
- Return on Invested Capital (ROIC)
- ―
- Return on Capital Employed (ROCE)
- ―
- Revenue Per Employee
- ―
- Profits Per Employee
- 371.12K
- Employee Count
- 6,000
- Asset Turnover
- ―
- Inventory Turnover
- ―
Income Statement
In the last 12 months, Beximco Pharmaceuticals Limited Sponsored GDR RegS had revenue of ― and earned 2.23B in profits. Earnings per share was ―.
- Revenue
- ―
- Gross Profit
- 7.18B
- Operating Income
- 3.30B
- Pretax Income
- ―
- Net Income
- 2.23B
- EBITDA
- 3.51B
- Earnings Per Share (EPS)
- ―
Dividends & Yields
Beximco Pharmaceuticals Limited Sponsored GDR RegS pays an annual dividend of GBX 3.35, resulting in a dividend yield of 7.52%
- Dividend Per Share
- GBX 3.35
- Dividend Yield
- 7.52%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- ―
- Earnings Yield
- ―
Stock Price Statistics
- Beta
- -0.18
- 52-Week Price Change
- 41.98%
- 50-Day Moving Average
- 56.79
- 200-Day Moving Average
- 47.64
- Relative Strength Index (RSI)
- 51.57
- Average Volume (3m)
- 22.80K
Important Dates
Beximco Pharmaceuticals Limited Sponsored GDR RegS upcoming earnings date is Feb 02, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Nov 09, 2026
- Next Earnings Date
- Feb 02, 2027
- Ex-Dividend Date
- Nov 22, 2024
Balance Sheet
Beximco Pharmaceuticals Limited Sponsored GDR RegS has ― in cash and marketable securities with GBX 8.94B in debt, giving a net cash position of ― billion.
- Cash & Marketable Securities
- ―
- Total Debt
- GBX 8.94B
- Net Cash
- ―
- Net Cash Per Share
- ―
- Tangible Book Value Per Share
- ―
Analyst Forecast
The average price target for Beximco Pharmaceuticals Limited Sponsored GDR RegS is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- 0
- Revenue Growth Forecast
- 3.86%
- EPS Growth Forecast
- 19.11%
Scores
- Smart Score
- 6
- AI Score
- ―

